These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 7010208)

  • 1. Antifibrinolytic therapy in subarachnoid hemorrhage caused by ruptured intracranial aneurysm.
    Ramirez-Lassepas M
    Neurology; 1981 Mar; 31(3):316-22. PubMed ID: 7010208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifibrinolytic therapy in patients with aneurysmal subarachnoid hemorrhage. A report of the cooperative aneurysm study.
    Adams HP; Nibbelink DW; Torner JC; Sahs AL
    Arch Neurol; 1981 Jan; 38(1):25-9. PubMed ID: 7458720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: a double-blind clinical trial.
    Chandra B
    Ann Neurol; 1978 Jun; 3(6):502-4. PubMed ID: 354483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifibrinolytic therapy in ruptured intracranial aneurysm through repeated monitoring of fibrinolytic activity of blood.
    Watanabe H; Ito M; Chigasaki H; Ishii S
    Neurol Med Chir (Tokyo); 1976; 16(PT1):91-6. PubMed ID: 66644
    [No Abstract]   [Full Text] [Related]  

  • 5. Antifibrinolytics in the treatment of subarachnoid hemorrhages due to ruptured aneurysms.
    Schisano G
    J Neurosurg Sci; 1975; 19(1-2):79-80. PubMed ID: 1082929
    [No Abstract]   [Full Text] [Related]  

  • 6. Intracranial aneurysms and subarachnoid hemorrhage. A cooperative study. Antifibrinolytic therapy in recent onset subarachnoid hemorrhage.
    Nibbelink DW; Torner JC; Henderson WG
    Stroke; 1975; 6(6):622-9. PubMed ID: 1198627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of antifibrinolytic therapy in the preoperative management of recently ruptured intracranial aneurysms.
    Guidetti B; Spallone A
    Surg Neurol; 1981 Apr; 15(4):239-48. PubMed ID: 6166061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of antifibrinolytic drugs in aneurysmal subarachnoid hemorrhage.
    Schisano G
    Surg Neurol; 1978 Oct; 10(4):217-22. PubMed ID: 725719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epsilon-aminocaproic acid and recurrent subarachnoid hemorrhage: a clinical trial.
    Shucart WA; Hussain SK; Cooper PR
    J Neurosurg; 1980 Jul; 53(1):28-31. PubMed ID: 7411206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage.
    Baharoglu MI; Germans MR; Rinkel GJ; Algra A; Vermeulen M; van Gijn J; Roos YB
    Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD001245. PubMed ID: 23990381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral complication of antifibrinolytic therapy in the treatment of ruptured intracranial aneurysm. Animal experiment and a review of literature.
    Yamaura A; Nakamura T; Makino H; Hagihara Y
    Eur Neurol; 1980; 19(2):77-84. PubMed ID: 6893025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative treatment of ruptured intracranial aneurysms with tranexamic acid and monitoring of fibrinolytic activity.
    Alvarez Garijo JA; Vilches JJ; Aznar JA
    J Neurosurg; 1980 Apr; 52(4):453-5. PubMed ID: 7373370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term tranexamic acid treatment in aneurysmal subarachnoid hemorrhage.
    Wijdicks EF; Hasan D; Lindsay KW; Brouwers PJ; Hatfield R; Murray GD; van Gijn J; Vermeulen M
    Stroke; 1989 Dec; 20(12):1674-9. PubMed ID: 2595729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative clinical trial of epsilon amino-caproic acid and tranexamic acid in the prevention of early recurrence of subarachnoid haemorrhage.
    Chowdhary UM; Sayed K
    J Neurol Neurosurg Psychiatry; 1981 Sep; 44(9):810-3. PubMed ID: 7031186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms?
    Maurice-Williams RS
    Br Med J; 1978 Apr; 1(6118):945-7. PubMed ID: 346153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolytic activity in blood and cerebrospinal fluid in subarachnoid hemorrhage from ruptured intracranial saccular aneurysm before and during EACA treatment.
    Filizzolo F; D'angelo V; Collice M; Ferrara M; Donati MB; Porta M
    Eur Neurol; 1978; 17(1):43-7. PubMed ID: 624294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tranexamic acid in the preoperative management of ruptured intracranial aneurysms.
    Fodstad H; Liliequist B; Schannong M; Thulin CA
    Surg Neurol; 1978 Jul; 10(1):9-15. PubMed ID: 356311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifibrinolytic treatment in subarachnoid hemorrhage.
    Vermeulen M; Lindsay KW; Murray GD; Cheah F; Hijdra A; Muizelaar JP; Schannong M; Teasdale GM; van Crevel H; van Gijn J
    N Engl J Med; 1984 Aug; 311(7):432-7. PubMed ID: 6379455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A method for monitoring antifibrinolytic therapy in patients with ruptured intracranial aneurysms.
    Burchiel KJ; Schmer G
    J Neurosurg; 1981 Jan; 54(1):12-5. PubMed ID: 7463112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative management of patients with aneurysmal subarachnoid hemorrhage.
    Tovi D
    J Neurosurg Sci; 1975; 19(1-2):59-64. PubMed ID: 1221096
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.